Risk factor | Treatment outcome | Univariable analysis for failure | Multivariable analysis for failure | |||
Failure (n = 1412) | Success (n = 9123) | OR (95% CI) | p Value | ORa (95% CI) | p Value | |
Sex | 1 | 1 | 0.003 | |||
Female | 551 | 4262 | 1.37 (1.22, 1.54) | <0.001 | 1.27 (1.08–1.49) | |
Male | 859 | 4848 | ||||
Age (y) | p trend | <0.001 | p trend | <0.001 | ||
<15 | 48 | 622 | 1 | 1.93 (0.92, 4.06) | ||
15–44 | 678 | 5311 | 1.65 (1.22, 2.24) | 2.29 (1.07, 4.9) | ||
45–64 | 275 | 1838 | 1.94 (1.41, 2.67) | 4.33 (2.02, 9.25) | ||
65+ | 411 | 1350 | 3.95 (2.88, 5.40) | |||
Place of birth | ||||||
UK | 469 | 2724 | 1 | 1 | ||
Abroad | 762 | 5672 | 0.78 (0.69, 0.88) | <0.001 | 1.07 (0.82, 1.38) | 0.629 |
Unknown | 181 | 727 | 1.45 (1.2, 1.75) | <0.001 | 1.60 (1.19, 2.15) | 0.002 |
Ethnic group | ||||||
White Caucasian | 496 | 2277 | 1 | 1 | ||
Black African | 51 | 284 | 0.83 (0.60, 1.13) | 0.227 | 1.17 (0.76, 1.81) | 0.47 |
Black Caribbean | 255 | 1780 | 0.66 (0.56, 0.77) | <0.001 | 1.24 (0.90, 1.72) | 0.194 |
India/Pakistani/Bangladesh | 208 | 1234 | 0.77 (0.65, 0.92) | 0.004 | 1.16 (0.83, 1.61) | 0.38 |
Other | 402 | 3548 | 0.52 (0.45, 0.60) | <0.001 | 0.70 (0.56, 0.79) | 0.01 |
Site of disease | ||||||
EPTB | 468 | 3846 | 1 | 1 | ||
PTB | 922 | 5156 | 1.48 (1.31, 1.66) | <0.001 | 1.28 (1.08, 1.53) | 0.006 |
Region | ||||||
Out of London | 559 | 4472 | 1 | 1.48 (1.31, 1.68) | <0.001 | |
London | 853 | 4651 | 1.47 (1.31, 1.64) | <0.001 | ||
History of previous Rx | ||||||
No | 1340 | 8786 | 1 | |||
Yes | 55 | 283 | 1.27 (0.95, 1.71) | 0.107 | ||
Culture result | ||||||
Negative | 583 | 3709 | 1 | |||
Positive | 829 | 5414 | 0.97 (0.87, 1.09) | 0.652 | ||
Any drug resistance | ||||||
No | 683 | 4597 | 1 | 1 | ||
Yes | 81 | 323 | 1.69 (1.31, 2.18) | <0.001 | 1.90 (1.44, 2.52) | <0.001 |
MDR | ||||||
No | 754 | 4889 | 1 | 1 | ||
Yes | 10 | 31 | 2.09 (1.02, 4.28) | 0.044 | 1.21 (0.56, 2.61) | 0.635 |
The model for the multivariable analysis included all variables that were significantly associated with treatment outcome in the single variable analysis.
EPTB, extrapulmonary tuberculosis; MDR, multi-drug resistance; OR, odds ratio; ORa, adjusted odds ratio; PTB, pulmonary tuberculosis; Rx, treatment.